Receipt of Assessment Order(s) from Income Tax Department

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.6%1-day move

₹512.50

prior close

₹516.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2-0.3-0.5-0.6+1.6+1.7+3.8+4.6+2.0+3.8+21.6+20.0+35.6—

Up moveDown movePending

AI summary

Akums Drugs and Pharmaceuticals Ltd and its subsidiary Akumentis Healthcare Ltd (AHL) have received assessment orders from the Income Tax Department under Section 158BC of the Income Tax Act for the block period April 1, 2018 to March 12, 2025. The Company faces a tax demand of Rs 60.09 crore while AHL faces a demand of Rs 73.66 crore, totaling approximately Rs 133.75 crore. The demands arise from disallowance of various expenditures under Section 37(1) of the Income Tax Act. The Company has stated that based on internal assessment, it does not expect material financial impact as the demands are not sustainable in law and are defendable. Both entities plan to pursue appeals against the orders.

Likely market impact

While the combined tax demand of Rs 133.75 crore is significant, the Company considers it defendable and plans to appeal, reducing immediate shareholder concern. However, prolonged litigation could have eventual financial implications if appeals are unsuccessful.